Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study

Nadia R.P.W. Hutten*, Natasha L. Mason, Patrick C. Dolder, Eef L. Theunissen, Friederike Holze, Matthias E. Liechti, Amanda Feilding, Johannes G. Ramaekers, Kim P.C. Kuypers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

There is a popular interest in microdosing with psychedelics such as LSD. This practice of using one-tenth of a full psychedelic dose according to a specific dosing schedule, anecdotally enhances mood and performance. Nonetheless, controlled research on the efficacy of microdosing is scarce. The main objective of the present dose-finding study was to determine the minimal dose of LSD needed to affect mood and cognition. A placebo-controlled within-subject study including 24 healthy participants, was conducted to assess the acute effects of three LSD doses (5, 10, and 20 mcg) on measures of cognition, mood, and subjective experience, up until 6 h after administration. Cognition and subjective experience were assessed using the Psychomotor Vigilance Task, Digit Symbol Substitution Test, Cognitive Control Task, Profile of Mood States, and 5-Dimensional Altered States of Consciousness rating scale. LSD showed positive effects in the majority of observations by increasing positive mood (20 mcg), friendliness (5, 20 mcg), arousal (5 mcg), and decreasing attentional lapses (5, 20 mcg). Negative effects manifested as an increase in confusion (20 mcg) and anxiety (5, 20 mcg). Psychedelic-induced changes in waking consciousness were also present (10, 20 mcg). Overall, the present study demonstrated selective, beneficial effects of low doses of LSD on mood and cognition in the majority of observations. The minimal LSD dose at which subjective and performance effects are notable is 5 mcg and the most apparent effects were visible after 20 mcg. (c) 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

Original languageEnglish
Pages (from-to)81-91
Number of pages11
JournalEuropean Neuropsychopharmacology
Volume41
Early online date17 Oct 2020
DOIs
Publication statusPublished - Dec 2020

Keywords

  • Attention
  • Healthy
  • LSD
  • Microdose
  • Mood
  • Psychedelic experience
  • TASK
  • PERFORMANCE
  • LYSERGIC-ACID DIETHYLAMIDE
  • EXPERIENCES
  • INDIVIDUAL-DIFFERENCES
  • DRUGS
  • DIGIT SYMBOL SUBSTITUTION
  • D-AMPHETAMINE

Fingerprint

Dive into the research topics of 'Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study'. Together they form a unique fingerprint.

Cite this